The present study demonstrates that, in addition to the breast cancer patients with germline BRCA1/2 mutation, the patients with wild-type BRCA1/2 who are high-risk of having hereditary breast cancer (BRCAx) also carry an increased risk of CBC recurrence when compared to that of low-risk patients. Here, BRCA1 is linked to breast carcinoma.